Compare · MDLN vs TRXC
MDLN vs TRXC
Side-by-side comparison of Medline Inc. (MDLN) and TransEnterix, Inc. (TRXC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and TRXC operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN carries a market cap of $51.08B.
- MDLN has hit the wire 5 times in the past 4 weeks while TRXC has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 0 for TRXC).
- Company
- Medline Inc.
- TransEnterix, Inc.
- Price
- $38.89-2.29%
- -
- Market cap
- $51.08B
- -
- 1M return
- +6.77%
- -
- 1Y return
- -4.56%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- AMEX
- IPO
- 2025
- n/a
- News (4w)
- 5
- 0
- Recent ratings
- 25
- 0
Latest MDLN
- Medline strengthens California distribution network with new 1 million-square-foot facility in Perris
- Medline Inc. filed SEC Form 8-K: Leadership Update
- Medline announces Prime Vendor agreement with Allina Health
- Securing new 1.6-plus million square feet of new space after fire, Medline leases two large distribution centers in Northern California
- Medline to report second quarter 2026 results on August 5, 2026
- Officer Abrams William J covered exercise/tax liability with 1,308 shares, decreasing direct ownership by 7% to 16,546 units (SEC Form 4)
- Chief Human Resources Officer Shryock Christopher P covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Operating Officer Miller Stephen L covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Legal Officer Liberman Alexander M. covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Product Officer Laabs Amanda H. covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
Latest TRXC
- SEC Form 8-K filed
- SEC Form 10-K filed
- Asensus Surgical, Inc. Schedules Fourth Quarter and Fiscal Year 2020 Financial and Operating Results Conference Call for March 11, 2021
- SEC Form 8-K filed
- Asensus Surgical Announces FDA Clearance in General Surgery
- Asensus Surgical to Present at the H.C. Wainwright Virtual Global Life Sciences Conference
- SEC Form 8-K filed
- SEC Form 8-K filed
- TransEnterix Announces Name Change to Asensus Surgical and Introduces a New Category of Surgery, Performance-Guided Surgery
- TransEnterix Announces New Training Center in EU